Asthma and Obstructive Airway Disease

Asthma is a chronic inflammatory disorder of the airways characterised by variable, reversible airflow obstruction and bronchial hyper-responsiveness, producing recurrent episodes of wheeze, cough, breathlessness, and chest tightness. It is the most common chronic disease of childhood worldwide and the leading example of an obstructive airway disease seen in pediatric practice.

Definition

Asthma is a heterogeneous disease usually characterised by chronic airway inflammation, defined by a history of respiratory symptoms (wheeze, breathlessness, chest tightness, cough) that vary over time and in intensity, together with variable expiratory airflow limitation.

Scope

This entry covers asthma as a pediatric chronic condition: its inflammatory basis, the physiology of reversible airflow obstruction, its epidemiology and changing prevalence, and the way it is classified by symptom control. It treats asthma as a reference topic within chronic systemic disease of childhood and does not provide individualised diagnostic or treatment instructions.

Core questions

• What distinguishes asthma from other causes of recurrent wheeze in children?
• How does chronic airway inflammation produce variable, reversible airflow obstruction?
• Why has the prevalence of childhood asthma changed over recent decades, and how does it vary by region?
• How is asthma severity and control conceptualised over the long term?

Key concepts

• Airway inflammation
• Reversible airflow obstruction
• Bronchial hyper-responsiveness
• Atopy and allergic sensitization
• Type 2 (eosinophilic) versus non-type-2 inflammation
• Airway remodeling
• Asthma control and exacerbations

Mechanisms

Asthma is driven by chronic inflammation of the airway wall, in many children associated with allergic (type 2) immune responses involving eosinophils and T-helper-2 cytokines. Inflammation produces bronchial hyper-responsiveness, so that triggers such as allergens, viral infection, exercise, or irritants provoke bronchial smooth-muscle constriction, mucosal oedema, and mucus secretion, narrowing the airway and limiting expiratory airflow. A defining feature is that this obstruction is variable and substantially reversible, spontaneously or with bronchodilators. Persistent inflammation can over time lead to structural airway remodeling (Papi et al., 2018).

Clinical relevance

Asthma is the most common chronic disease of childhood and a frequent reason for emergency visits, hospital admissions, and missed school. Understanding its inflammatory and obstructive basis underpins how clinicians recognise the disease and assess control over time. This entry describes the disease conceptually and is not a basis for individual diagnostic or treatment decisions.

Epidemiology

Asthma affects a large share of children globally, and the international ISAAC surveys documented wide geographic variation and shifting time trends in childhood asthma symptom prevalence (Asher et al., 2006). Global Burden of Disease analyses confirm that asthma contributes substantially to years lived with disability across populations (James et al., 2018). Prevalence is generally higher in high-income and urbanising settings, and many affected children have associated atopic conditions.

Evidence & guidelines

Asthma definition, classification by control, and the inflammatory framework summarised here draw on a major narrative synthesis of the disease (Papi et al., 2018); international epidemiologic surveys (Asher et al., 2006) and Global Burden of Disease analyses (James et al., 2018) provide the population evidence. Specific management algorithms are governed by current international and national consensus guidance, which this reference entry does not reproduce.

History

Asthma has been described since antiquity as episodic breathlessness, but its modern understanding shifted decisively in the late twentieth century from a primarily bronchoconstrictive disorder to one centred on chronic airway inflammation. This reframing established inflammation, rather than smooth-muscle spasm alone, as the core process, and the recognition of distinct inflammatory phenotypes has more recently refined the concept further (Papi et al., 2018).

Debates

Why has childhood asthma prevalence risen in many regions?

International surveys document substantial increases and geographic variation in childhood asthma over recent decades; hygiene, allergen exposure, urbanisation, and environmental factors have all been proposed, but the relative contributions remain debated.

Seminal works

• papi-2018
• asher-2006-isaac

Frequently asked questions

Is childhood wheeze always asthma?

No. Recurrent wheeze in young children has several causes, including viral airway infections; asthma is distinguished by a pattern of variable respiratory symptoms together with variable, reversible airflow limitation, and not every wheezing child meets that definition.

What does it mean that asthma airflow obstruction is 'reversible'?

It means the airway narrowing that produces symptoms can substantially improve, either on its own or in response to bronchodilator medication, distinguishing asthma from fixed obstructive diseases.